Clinical Trial Available for Patients with Advanced & Metastatic Pancreatic Cancer

New Clinical Trial Available Now for Patients with Advanced & Metastatic Pancreatic Cancer

Are you, or someone you know, being treated for Advanced or Metastatic Pancreatic Cancer with chemotherapy alone? Contact Dr. Robert Donoway at Atlas Oncology in Hollywood, Florida.

Dr. Donoway is leading a new clinical trial using multi-modality therapy: combining Pancreatic Nanoknife Ablation with chemoimmuno-radiotherapy to treat advanced stage cancer patients from around the world.

With over 35 years of experience performing pancreatic surgery in South Florida, Dr. Donoway recognized that, because of its late diagnosis, up to 85% of the patients treated with surgery for pancreatic cancer already had metastatic disease. This fact limits the benefit a patient might get from the Whipple surgery.

Recent evidence shows that when even advanced disease is treated aggressively in an integrated approach, incorporating Nanoknife surgery with chemotherapy, long-term survivorship can be achieved, especially compared to chemotherapy alone.

Dr. Donoway has been a pioneer in the use of Pancreatic NanoKnife, especially for complex advanced cases. During the past decade, he remains the only surgical oncologist performing the procedure in South Florida. Patients from around the globe have traveled to benefit from this ground-breaking treatment, which is FDA approved. Dr. Donoway also treats other advanced cancers, such as liver, breast, and sarcomas, using Nanoknife surgery. A brief recovery means the patient can start chemotherapy and radiation that much sooner.

Dr. Donoway feels that “we are long overdue to revise our approach to treating pancreatic cancer. The treatment has remained largely unchanged for over 80 years and has just broken the 9-10% five-year survivorship barrier. Only thru thinking outside the box will we accomplish the positive. Otherwise, all we’re doing is confirming Einstein’s definition of Insanity.”

Dr. Donoway is participating in several clinical studies identifying the best chemotherapy and immunotherapies to be used along with IRE. Dr. Donoway states, “The results so far have been very encouraging and we have begun using it for other select cancers. Among his longest survivors are now patients over eight years without evidence of cancer recurrence. In the past, without IRE they would have been likely to have only lived a year and so this technique opens the whole new avenue for treating those eligible patients in a more targeted fashion.”

Dr. Donoway will be presenting the long-term results of his pancreatic treatment paradigm for advanced and metastatic disease later this fall at an International cancer society in Europe For more information about Dr. Donoway and the PancreaticIRE/NanoKnife Program and clinical trials call 305-682-1995 and visit www.AtlasOncology.com.

4000 Hollywood Boulevard • Suite 160 North • Hollywood, Florida 33021 Phone 954-986-6366, 305-682-1995 • Fax 954-986-4355 www.AtlasOncology.com

Robert B. Donoway, M.D., F.A.C.S., F.S.S.O.

Surgical Oncology & Pancreatic Surgical Oncology

Specializing in Cancer of the Pancreas, Liver, GI Tract, Sarcoma, Adrenal, Thyroid, Parathyroid, and Melanoma. Laparoscopic and Image Guided Cancer Surgery, IRE/NanoKnife for NonResectable Pancreatic and Liver Cancer.

Dr. Robert Donoway who is a board certified Fellowship-trained Surgical Oncologist, received his MD and Surgical training at the University of Pennsylvania. He completed his fellowship in Surgical Oncology at Sloan-Kettering where he was the General Motors Cancer Research Fellow. He has taught on the faculty at Penn, Sloan-Kettering, University of Miami and Nova Southeastern. Dr. Donoway is the former Medical Director of the Memorial Cancer Institute and Chairman of the Cancer Committee for the Memorial Healthcare System as well as the former Chief of Surgery and Surgical Oncology at Memorial Regional in Hollywood, South Florida.

Dr. Donoway served on the Board of the American Cancer Society & Gildas Club. He has also served as past President of the American Cancer Society Broward County Chapter. Dr. Donoway is active in the Society of Surgical Oncology and the American Pancreatic Association. His accomplishments include being the first Surgeon in Florida to perform Radio Frequency Ablation as well as Laparoscopic Liver Resection. Dr. Donoway is a former recipient of the South Florida Health Award for the use of Micro-Endoscopy for the detection of early stage Breast Cancer.

Dr. Donoway is the Medical Director of the Institute of Breast Cancer Prevention and has been repeatedly named to “TOP DOCTORS IN AMERICA” by Castle Connolly. Dr. Donoway is the ONLY surgeon in Florida performing specialized Pancreatic and Liver ablation therapy for non-resectable tumors. Dr. Donoway is the Former Chair of the Aventura Cancer Committee at Aventura Hospital and Medical Center.

Robert B. Donoway, M.D., F.A.C.S., F.S.S.O.

Diplomate American Board of Surgery Diplomate, Society of Surgical Oncology Former Medical Director & Memorial Cancer Center Medical Director, Atlas Oncology: Institute for Pancreatic Cancer IRE/NanoKnife Ablation

Continuing to Care For Our Patients During the Coronavirus Crisis • Now Offering Telemedicine • Office Maintains Strict Disinfection Protocol • Dr. Donoway Operates on Patients Four Days a Week